Emerging Imaging and Radiotherapy Techniques for CNS Tumors
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 30 April 2027 | Viewed by 18
Editors
Interests: neuro-oncology; stereotactic radiosurgery; advanced CNS imaging; molecular imaging; adaptive radiotherapy; connectomics-guided radiotherapy; precision radiation oncology; brain metastases; CNS theranostics
Interests: neuro-oncology; CNS malignancies; proton therapy; advanced radiotherapy techniques; stereotactic radiosurgery; translational neuro-oncology; CNS imaging; precision radiation oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Central nervous system (CNS) tumors remain among the most complex and challenging diseases in oncology, requiring highly specialized multidisciplinary care and precision-driven therapeutic strategies. Over the past decade, major advances in imaging technologies and radiation treatment techniques have significantly transformed the field of neuro-oncology. Emerging imaging modalities now enable improved tumor characterization, more accurate target delineation, earlier response assessment, and enhanced differentiation between treatment effect and disease progression. Simultaneously, modern radiotherapy techniques continue to improve conformality, facilitate adaptive and biologically guided treatment approaches, and reduce toxicity while preserving neurologic function and quality of life.
We are pleased to invite you to contribute to the Special Issue entitled “Emerging Imaging and Radiotherapy Techniques for CNS Tumors” in Cancers.
This Special Issue aims to highlight innovative developments in advanced imaging, precision radiotherapy, and translational neuro-oncology research related to primary and metastatic CNS tumors. The scope of this issue encompasses both technological advances and their clinical applications, with particular emphasis on imaging-guided radiation oncology and personalized treatment strategies.
In this Special Issue, original research articles and reviews are welcome. Areas of interest include advanced MRI techniques, functional neuroimaging, amino acid PET and molecular imaging applications, as well as DOTATATE imaging and theranostic approaches in neuro-oncology. We also welcome submissions focusing on radiomics, radiogenomics, artificial intelligence applications, imaging biomarkers, and advanced response assessment strategies. Additional topics of interest include adaptive and MR-guided radiotherapy, stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), proton therapy, FLASH radiotherapy, boron neutron capture therapy (BNCT), and re-irradiation approaches for CNS tumors. Manuscripts exploring cognitive-sparing and connectomics-guided radiotherapy, biologically guided and personalized radiation treatment strategies, and translational or multidisciplinary neuro-oncology research are also encouraged.
We look forward to receiving your contributions and to advancing the field of precision neuro-oncology through this Special Issue.
Dr. Tugce Kutuk
Prof. Dr. Joshua D. Palmer
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- CNS tumors
- neuro-oncology
- advanced imaging
- molecular imaging
- MRI
- PET imaging
- stereotactic radiosurgery (SRS)
- adaptive radiotherapy
- proton therapy
- stereotactic body radiotherapy (SBRT)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
